Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-EN
Language French English
Date Updated 2018-08-28 2018-08-16
Drug Identification Number 02299925 02299925
Brand name ATRIANCE ATRIANCE
Common or Proper name ATRIANCE INJ 5MG/ML 50ML X 6 ATRIANCE INJ 5MG/ML 50ML X 6
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients NELARABINE NELARABINE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ML X 6 50ML X 6
ATC code L01BB L01BB
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-08-31 2018-08-31
Actual start date
Estimated end date 2018-09-04 2018-09-04
Actual end date 2018-08-28
Shortage status Avoided shortage Anticipated shortage
Company comments
Health Canada comments